Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.99 USD | -4.32% | -4.77% | -38.04% |
Financials (USD)
Sales 2024 * | 30.47M | Sales 2025 * | 71.52M | Capitalization | 1.06B |
---|---|---|---|---|---|
Net income 2024 * | -174M | Net income 2025 * | -127M | EV / Sales 2024 * | 12.6 x |
Net cash position 2024 * | 678M | Net cash position 2025 * | 585M | EV / Sales 2025 * | 6.65 x |
P/E ratio 2024 * |
-5.05
x | P/E ratio 2025 * |
-7.61
x | Employees | 467 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 3.32% |
Latest transcript on Autolus Therapeutics plc
1 day | -4.32% | ||
1 week | -4.77% | ||
Current month | +8.42% | ||
1 month | -20.52% | ||
3 months | -42.92% | ||
6 months | +16.33% | ||
Current year | -38.04% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Pulé
FOU | Founder | 51 | 14-08-31 |
Chief Executive Officer | 59 | 14-09-30 | |
Robert Dolski
DFI | Director of Finance/CFO | 54 | 23-08-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Berriman
BRD | Director/Board Member | 76 | 14-07-31 |
William Young
BRD | Director/Board Member | 79 | 21-11-14 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 3.99 | -4.32% | 1,024,007 |
24-05-09 | 4.17 | +1.46% | 887,252 |
24-05-08 | 4.11 | +2.49% | 1,679,145 |
24-05-07 | 4.01 | -1.72% | 2,001,208 |
24-05-06 | 4.08 | -2.63% | 2,024,007 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.04% | 1.06B | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- AUTL Stock